Lisa McConlogue

Professor Lisa McConlogue is a research scientist with considerable pharmaceutical discovery and translational research experience including significant scientific discoveries, project management, strategic leadership, and external industrial and academic partnerships. Ms. McConlogue has over 20 years of experience in the biotechnology and pharmaceutical industry, focused on identifying novel therapeutic approaches for neurodegenerative diseases characterized by protein misfolding, such as Parkinson’s disease and Alzheimer’s disease, and is a recognized expert with a broad understanding of both drug discovery and basic research.

She has developed key animal models, identified and validated therapeutic targets and developed therapeutic lead molecules to the point of preclinical development, as well as demonstrated the ability to integrate basic science and translational research, drive novel efforts, and lead inter-institutional and multi-departmental collaborations. Ms. McConlogue has led large discovery programs coordinating input from cross-functional specialists including joint Elan-University of Cambridge institute, was a principal scientist at Elan Pharmaceuticals (acquired by Perrigo for USD 8.6bn) and holds a Ph.D. from UCLA.